RABEPRAZOLE 20mg. IP + DOMPERIDONE 30mg. IP

An anti-ulcer and anti-emetic combination that addresses acid reflux, nausea and vomiting, and different types of ulcers. Demonstrates a significant and remarkable improvement in symptoms of gastroesophageal reflux disease. (Savita Shahani, 2008) Effectively addresses gastroesophageal reflux disorder than rabeprazole alone. A safe and well-tolerated agent for the treatment of laryngopharyngeal reflux disease. (K Semmanaselvan, 2015) An efficacious drug that provides a significant symptomatic improvement in laryngopharyngeal reflux disease individuals. (K Semmanaselvan, 2015) Improves the quality of life of patients suffering from gastro-esophageal reflux disease. (Savita Shahani, 2008)